GENFLOW BIOSCIENCES PLC (WQ5) — Financial Flexibility Index
Latest as of December 2024:
-1.37x
GENFLOW BIOSCIENCES PLC (WQ5) has a Financial Flexibility Index of -1.37x as of December 2024. Free cash flow of €-1.08 Million (operating CF €-1.08 Million minus capex €0.00) represents -1% of total liabilities (€788.92K).
Financial Flexibility Index
-1.37x
Free Cash Flow / Total Liabilities
Free Cash Flow
€-1.08 Million
Operating CF − Capex
Total Liabilities
€788.92K
EUR
Capital Expenditures
€0.00
EUR
GENFLOW BIOSCIENCES PLC Financial Flexibility Index (2021–2024)
Historical Financial Flexibility Index trend for GENFLOW BIOSCIENCES PLC across 4 annual periods. See how liquid is GENFLOW BIOSCIENCES PLC's working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for GENFLOW BIOSCIENCES PLC (2021–2024)
Year-by-year free cash flow to debt coverage for GENFLOW BIOSCIENCES PLC. For the full company profile including market capitalisation, see WQ5 market cap.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.37x | €-1.08 Million | €-1.08 Million | €788.92K | ▲ +52.7% |
| 2023 | -2.90x | €-1.66 Million | €-1.66 Million | €571.96K | ▲ +46.7% |
| 2022 | -5.44x | €-1.37 Million | €-1.37 Million | €250.99K | ▼ -61.2% |
| 2021 | -3.38x | €-747.38K | €-747.38K | €221.43K | — |
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities